We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.18B
AUM Growth
-$93.5M
Cap. Flow
+$113M
Cap. Flow %
9.6%
Top 10 Hldgs %
21.21%
Holding
341
New
184
Increased
50
Reduced
82
Closed
18

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$12.6M
2
MFC icon
Manulife Financial
MFC
+$7.56M
3
GKOS icon
Glaukos
GKOS
+$7.01M
4
AMZN icon
Amazon
AMZN
+$6.67M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.26M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$11.7M
2
UNH icon
UnitedHealth
UNH
+$11.3M
3
IRTC icon
iRhythm Holdings
IRTC
+$9.63M
4
HALO icon
Halozyme
HALO
+$8.33M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$7.47M

Sector Composition

Rank Sector Weight
1 Healthcare 46.65%
2 Financials 13.97%
3 Consumer Discretionary 13.94%
4 Technology 8.36%
5 Industrials 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPGI icon
51
S&P Global
SPGI
$121B
$5.68M 0.48%
+16,867
New +$6.01M
MTZ icon
52
MasTec
MTZ
$22.6B
$5.68M 0.48%
79,225
+59,346
+299% +$4.63M
TWST icon
53
Twist Bioscience
TWST
$7.85B
$5.67M 0.48%
162,296
-52,405
-24% -$1.86M
AMZN icon
54
Amazon
AMZN
$2.88T
$5.66M 0.48%
+53,277
New +$6.67M
CARR icon
55
Carrier Global
CARR
$52B
$5.5M 0.47%
154,179
+103,262
+203% +$4.05M
JLL icon
56
Jones Lang LaSalle
JLL
$16.7B
$5.35M 0.45%
+30,597
New +$6.1M
GOOG icon
57
Alphabet (Google) Class C
GOOG
$4.19T
$5.34M 0.45%
+48,840
New +$5.77M
BN icon
58
Brookfield
BN
$110B
$5.32M 0.45%
222,178
+167,726
+308% +$4.48M
MRTX
59
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.08M 0.43%
75,745
+36,653
+94% +$2.33M
TSLA icon
60
Tesla
TSLA
$1.29T
$4.98M 0.42%
+22,203
New +$6.06M
JNJ icon
61
Johnson & Johnson
JNJ
$629B
$4.94M 0.42%
27,842
+13,458
+94% +$2.4M
CPRT icon
62
Copart
CPRT
$26.8B
$4.88M 0.41%
+179,820
New +$5.12M
HASI icon
63
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.37B
$4.83M 0.41%
127,694
+100,364
+367% +$3.99M
EXAS
64
DELISTED
Exact Sciences
EXAS
$4.59M 0.39%
116,460
-5,749
-5% -$307K
IOVA icon
65
Iovance Biotherapeutics
IOVA
$3.05B
$4.55M 0.39%
412,088
-174
-0% -$2.28K
IMGN
66
DELISTED
Immunogen Inc
IMGN
$4.52M 0.38%
1,004,626
-1,270,783
-56% -$5.52M
NVDA icon
67
NVIDIA
NVDA
$5.43T
$4.35M 0.37%
286,900
+75,370
+36% +$1.42M
URI icon
68
United Rentals
URI
$70.3B
$4.32M 0.37%
+17,795
New +$5.24M
KURA icon
69
Kura Oncology
KURA
$882M
$4.29M 0.36%
234,273
-99
-0% -$1.42K
CCK icon
70
Crown Holdings
CCK
$13.1B
$4.15M 0.35%
45,025
+33,958
+307% +$3.63M
TDOC icon
71
Teladoc Health
TDOC
$1.22B
$4.13M 0.35%
124,265
-5,053
-4% -$215K
CRSP icon
72
CRISPR Therapeutics
CRSP
$5.22B
$3.86M 0.33%
63,569
-127,116
-67% -$7.47M
AGCO icon
73
AGCO
AGCO
$7.11B
$3.83M 0.32%
38,821
+28,266
+268% +$3.52M
ACN icon
74
Accenture
ACN
$110B
$3.83M 0.32%
+13,775
New +$4.14M
ADBE icon
75
Adobe
ADBE
$103B
$3.81M 0.32%
+10,396
New +$4.23M
1 2
3
4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q2 2022 Portfolio in Review

As of Q2 2022, Lombard Odier Asset Management (Switzerland) held 341 positions worth $1.18B, down 7.3% from $1.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lombard Odier Asset Management (Switzerland) deployed $113M of net new capital in Q2 2022, opening 184 new positions and adding to 50 existing holdings. Its largest new stake was Glaukos: 147,742 shares worth $6.71M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 57% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $11.7M trimmed.

  • Lombard Odier Asset Management (Switzerland)'s largest Q2 2022 buy was Glaukos: 147,742 shares worth $6.71M.
  • Lombard Odier Asset Management (Switzerland) added most to DexCom in Q2 2022, an estimated $12.6M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q2 2022 reduction was AbbVie, cutting an estimated $11.7M.
  • Lombard Odier Asset Management (Switzerland) fully exited G1 Therapeutics, Inc. Common Stock in Q2 2022, selling an estimated $4.12M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 21% of its $1.18B portfolio in Q2 2022.
  • Lombard Odier Asset Management (Switzerland) opened 184 new positions and closed 18 in Q2 2022.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 7.3% quarter-over-quarter to $1.18B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 15 Aug 2022.